<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-25313" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Mucinous Breast Carcinoma</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Limaiem</surname>
            <given-names>Faten</given-names>
          </name>
          <aff>University of Tunis El Manar, Tunis Faculty of Medicine</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Ahmad</surname>
            <given-names>Faran</given-names>
          </name>
          <aff>Creighton University Medical Center</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Faten Limaiem declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Faran Ahmad declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>12</day>
          <month>2</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-25313.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Mucinous carcinoma of the breast is a relatively rare subtype of breast cancer, accounting for about 2% of all breast carcinomas. According to the latest WHO classification of tumors of the breast, mucinous carcinoma is classified as a special type of breast cancer. This activity describes the pathophysiology, etiology, and presentation of mucinous breast cancer and highlights the role of the interprofessional team in its management.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify&#x000a0;the pathophysiology of mucinous breast cancer.</p></list-item><list-item><p>Assess&#x000a0;the evaluation of a patient with mucinous breast cancer.</p></list-item><list-item><p>Evaluate&#x000a0;the treatment options for mucinous breast cancer.</p></list-item><list-item><p>Communicate&#x000a0;the importance of improving care coordination among interprofessional team members to improve outcomes for patients affected by mucinous breast cancer.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=25313&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=25313">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-25313.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Mucinous carcinoma of the breast is a relatively rare subtype of breast cancer, accounting for about 2% of all breast carcinomas (see <bold>Image.</bold>&#x000a0;Mucinous&#x000a0;Cancer).<xref ref-type="bibr" rid="article-25313.r1">[1]</xref>&#x000a0;According to the latest WHO classification of tumors of the breast, mucinous carcinoma is classified as a special type of breast cancer. Based on the cellularity of the tumor, mucinous carcinomas are divided into&#x000a0;two subtypes:</p>
        <list list-type="bullet">
          <list-item>
            <p>The pure type mucinous carcinoma.</p>
          </list-item>
          <list-item>
            <p>The mixed type mucinous carcinoma.</p>
          </list-item>
        </list>
        <p>The pure type consists exclusively of tumor tissue with extracellular mucin production in over 90% of the tumor, while the mixed form also contains an infiltrating ductal epithelial component without mucin <xref ref-type="bibr" rid="article-25313.r2">[2]</xref>.&#x000a0;Mucinous breast cancer&#x000a0;carries a favorable prognosis with a low recurrence rate and&#x000a0;a low incidence of lymph node metastasis. The definitive diagnosis and classification of mucinous breast carcinomas&#x000a0;are mainly based on histopathological examination.</p>
      </sec>
      <sec id="article-25313.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>The origin of mucinous breast cancer is multifactorial and involves diet, reproductive factors, and hormones.</p>
      </sec>
      <sec id="article-25313.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Mucinous breast carcinoma&#x000a0;prevails in postmenopausal women with a median age of 70 years&#x000a0;<xref ref-type="bibr" rid="article-25313.r3">[3]</xref>. Pure mucinous carcinoma is rarely&#x000a0;encountered in young patients under 35 (1%)<xref ref-type="bibr" rid="article-25313.r2">[2]</xref>.&#x000a0;</p>
      </sec>
      <sec id="article-25313.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Transcriptomic studies have demonstrated that mucinous tumors are of luminal A molecular subtype <xref ref-type="bibr" rid="article-25313.r4">[4]</xref>. The transcriptomic features of mucinous A are distinct from those of mucinous B tumors, the latter showing a gene expression pattern similar to neuroendocrine carcinomas <xref ref-type="bibr" rid="article-25313.r4">[4]</xref>. Pure mucinous carcinomas harbor a low level of genetic instability and rare recurrent amplifications, and the genomic profiles of the tumor components of mixed mucinous tumors are remarkably similar to those of pure mucinous carcinomas.&#x000a0;More than 90% of pure mucinous carcinomas&#x000a0;are diploid, whereas only 42%&#x000a0;of mixed mucinous carcinomas are diploid&#x000a0;<xref ref-type="bibr" rid="article-25313.r5">[5]</xref>.</p>
      </sec>
      <sec id="article-25313.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>
<bold>Macroscopic findings:</bold>
</p>
        <p>A gross examination of mucinous carcinoma of the breast shows a glistening gelatinous lesion with pushing margins and a readily recognizable soft consistency. The tumors range from less than 1 cm to over 20 cm (mean = 3 cm).</p>
        <p>
<bold>Microscopic findings:</bold>
</p>
        <p>Histologically, mucinous carcinoma is characterized by nests of cells floating in lakes of mucin partitioned by delicate fibrous septae containing capillary blood vessels. The cell clusters are variable in shape and size with an occasional tubular arrangement. Nuclear atypia is generally low in classic mucinous carcinoma, but in rare cases, atypia and mitoses may prevail <xref ref-type="bibr" rid="article-25313.r6">[6]</xref>. A micropapillary or cribriform intraepithelial component is rarely seen. Mucinous carcinoma presenting with large cell clusters, reported by Capella as hypercellular or type B mucinous carcinoma, shows frequent neuroendocrine differentiation <xref ref-type="bibr" rid="article-25313.r7">[7]</xref>. Type A mucinous carcinoma with larger quantities of extracellular mucin represents the classic non-endocrine variety. Pure and mixed variants have been described <xref ref-type="bibr" rid="article-25313.r8">[8]</xref>. The most common admixture is with invasive carcinoma of no special type. A pure tumor must be composed of more than 90% mucinous carcinoma <xref ref-type="bibr" rid="article-25313.r6">[6]</xref>.&#x000a0;The in situ component may have a papillary, micropapillary, or cribriform pattern. In some cases, the in situ carcinoma may exhibit prominent luminal mucin production. Neuroendocrine differentiation can sometimes be identified using immunohistochemistry and special stains (Grimelius).&#x000a0;</p>
        <p>
<bold>Immunohistochemistry:</bold>
</p>
        <p>Typically, mucinous carcinoma is positive for estrogen and progesterone receptors <xref ref-type="bibr" rid="article-25313.r9">[9]</xref>, while androgen receptors are expressed at a low level, and HER2 is not amplified <xref ref-type="bibr" rid="article-25313.r10">[10]</xref>. Pure and mixed mucinous carcinomas are reported to express WT <xref ref-type="bibr" rid="article-25313.r11">[11]</xref>. Mucinous breast carcinoma expresses predominantly MUC2 and MUC6 among the family of MUC genes <xref ref-type="bibr" rid="article-25313.r12">[12]</xref>.</p>
      </sec>
      <sec id="article-25313.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Mucinous carcinoma usually grows slowly and can&#x000a0;reach a&#x000a0;large&#x000a0;size&#x000a0;during diagnosis. This can be explained by the fact that the mucinous content of the tumor does not feel firm or solid upon examination&#x000a0;<xref ref-type="bibr" rid="article-25313.r13">[13]</xref>. Most patients with mucinous breast carcinoma present with a palpable breast mass. Fixation to the skin or chest wall is rare&#x000a0;but is reported in large lesions. With widespread screening, many patients are diagnosed because of a mammographic abnormality <xref ref-type="bibr" rid="article-25313.r14">[14]</xref>.</p>
      </sec>
      <sec id="article-25313.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>
<bold>Mammography:</bold>
</p>
        <p>On mammography, circumscribed and lobulated breast lesions&#x000a0;are common findings for a mucinous carcinoma. A circumscribed margin would favor the diagnosis of a pure mucinous carcinoma <xref ref-type="bibr" rid="article-25313.r15">[15]</xref>.</p>
        <p>
<bold>Ultrasonography:</bold>
</p>
        <p>On ultrasonography, mucinous carcinoma is usually a complex mass with cystic and solid components, including microlobulation, vascularity, and distal enhancement. The histologic subtype of mucinous carcinoma can be predicted based on echogenicity. Isoechoic masses&#x000a0;are found in pure mucinous carcinoma, whereas hypoechoic masses are found in mixed mucinous carcinoma <xref ref-type="bibr" rid="article-25313.r16">[16]</xref>.</p>
        <p>
<bold>Magnetic resonance imaging:</bold>
</p>
        <p>On an MRI, mucinous carcinoma has a lobular shape, rim or heterogeneous enhancement, a&#x000a0;persistent pattern on the time-intensity curve, and homogeneous strongly high signal intensity on T2-weighted images&#x000a0;<xref ref-type="bibr" rid="article-25313.r17">[17]</xref>&#x000a0;<xref ref-type="bibr" rid="article-25313.r15">[15]</xref>.&#x000a0;</p>
        <p>
<bold>Tissue biopsy:</bold>
</p>
        <p>Tissue biopsy is&#x000a0;mandatory in the evaluation of mucinous breast carcinoma. Tissue specimens can be obtained by core biopsy,&#x000a0;fine needle aspiration cytology, and incisional or excisional biopsy.</p>
      </sec>
      <sec id="article-25313.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>The treatment of mucinous breast carcinoma is based on surgery associated with post-operative&#x000a0;hormone therapy&#x000a0;in hormone-responsive (estrogen/progesterone) tumors. A recent&#x000a0;study recommended axillary staging by sentinel lymph node biopsy and administration of adjuvant radiotherapy and&#x000a0;hormone therapy after breast-conservation for mucinous carcinoma <xref ref-type="bibr" rid="article-25313.r9">[9]</xref><xref ref-type="bibr" rid="article-25313.r18">[18]</xref>. Since&#x000a0;most mucinous carcinomas&#x000a0;are negative for the protein HER2/neu, they&#x000a0;are not treated with trastuzumab. Trastuzumab is approved for both the treatment of advanced breast cancer and as adjuvant therapy for early-stage HER2-positive tumors <xref ref-type="bibr" rid="article-25313.r19">[19]</xref>. Some authors have stated that&#x000a0;adjuvant chemotherapy&#x000a0;can be omitted in cases with favorable risk factors&#x000a0;<xref ref-type="bibr" rid="article-25313.r20">[20]</xref>.</p>
      </sec>
      <sec id="article-25313.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>
<bold>Histological differential diagnosis:</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Mucocele-like-lesion</p>
          </list-item>
          <list-item>
            <p>Metastatic mucinous carcinoma</p>
          </list-item>
        </list>
        <p>
<bold>Radiological differential diagnosis:</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Myxomatous fibroadenoma</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-25313.s11" sec-type="Treatment Planning ">
        <title>Treatment Planning </title>
        <p>The following factors may impact treatment decisions:</p>
        <list list-type="bullet">
          <list-item>
            <p>Tumor biology: Since mucinous carcinoma is more prevalent in the older population, estrogen and progesterone receptors are expressed&#x000a0;more often than in younger women. Similarly, there are lower rates of HER-2 overexpression. This impacts the selection of appropriate&#x000a0;therapy.</p>
          </list-item>
          <list-item>
            <p>General health status: A higher prevalence&#x000a0;of comorbidity, frailty,&#x000a0;and cognitive decline in elderly patients are considered limiting factors when selecting treatment.</p>
          </list-item>
          <list-item>
            <p>Functional status: This refers&#x000a0;to the ability to perform routine daily tasks. Functional limitation is independently associated with worse life expectancy and hence determines the overall survival of the patients. Comprehensive Geriatric Assessment (GCA) can be utilized to evaluate elderly patients and optimize mucinous cancer treatment.&#x000a0;</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-25313.s12" sec-type="Staging">
        <title>Staging</title>
        <p>Staging of mucinous breast carcinoma is determined clinically by physical examination and imaging studies. The stage is determined pathologically by histological examination of the tumor and lymph nodes after surgery. The TNM classification system is used to classify mucinous breast carcinoma based on:</p>
        <list list-type="bullet">
          <list-item>
            <p>Primary tumor size (T)</p>
          </list-item>
          <list-item>
            <p>Regional lymph node status (N)</p>
          </list-item>
          <list-item>
            <p>Distant metastasis (M)</p>
          </list-item>
        </list>
        <p>The system that is most recently used is that of the American Joint Committee on Cancer (8th edition).</p>
      </sec>
      <sec id="article-25313.s13" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Mucinous carcinoma&#x000a0;has a favorable prognosis and infrequent lymphatic metastasis compared to invasive ductal carcinoma. Axillary lymph node metastases occur in 12%-14% of the cases <xref ref-type="bibr" rid="article-25313.r19">[19]</xref>. Pure mucinous carcinoma has a better prognosis than mixed mucinous breast carcinoma&#x000a0;<xref ref-type="bibr" rid="article-25313.r3">[3]</xref>. The 5-year disease-free survival rates range from 81% to 94% (the latter if lymph nodes are negative). Late distant metastases may occur in pure mucinous carcinoma&#x000a0;<xref ref-type="bibr" rid="article-25313.r21">[21]</xref>. In a multivariate analysis of 11,422 patients with pure mucinous carcinoma,&#x000a0;tumor size was found to be an independent prognostic indicator but&#x000a0;less significant than nodal status <xref ref-type="bibr" rid="article-25313.r2">[2]</xref>.&#x000a0;Other studies have found that tumor size is not a significant prognostic factor and does not affect survival&#x000a0;since most tumor&#x000a0;volume consists of mucin<xref ref-type="bibr" rid="article-25313.r13">[13]</xref>.</p>
      </sec>
      <sec id="article-25313.s14" sec-type="Complications">
        <title>Complications</title>
        <p>Complications of breast mucinous carcinoma include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Axillary lymph node metastases</p>
          </list-item>
          <list-item>
            <p>Late distant metastases</p>
          </list-item>
          <list-item>
            <p>Recurrence after surgical excision</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-25313.s15" sec-type="Consultations">
        <title>Consultations</title>
        <p>Consultations that are typically requested for patients with breast mucinous carcinoma include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Surgical oncology</p>
          </list-item>
          <list-item>
            <p>Oncology</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-25313.s16" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Women aged 40 and over need to talk to a doctor, discuss the benefits and drawbacks of breast cancer screening, and decide when to get screening. Women 40 to 74 years old or some older healthy women may be offered a screening&#x000a0;test with the&#x000a0;mammogram. Some women who are at high risk (BRCA gene or first-degree relatives with breast cancer) may need to begin screening at a younger age. Nine&#x000a0;out of 10 women with an abnormal mammogram turn out not to have breast cancer.&#x000a0;Many experts suggest a screening mammogram every 2 years.</p>
      </sec>
      <sec id="article-25313.s17" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>The diagnosis of mucinous breast carcinoma requires an interprofessional team involving a surgical oncologist, an oncologist, a pathologist, and a radiologist. Treatment involves a surgeon, specialty care nurses, pharmacists, and oncologists. Pharmacists review drug regimens and check for drug-drug interactions. Specialty care nurses are involved and should assist the clinical team in patient education, monitor treatment, and provide feedback to the team. After treatment of mucinous breast carcinoma, long-term&#x000a0;follow-up is necessary to detect local and distant relapse.</p>
      </sec>
      <sec id="article-25313.s18">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=25313&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=25313">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/cancer/mucinous-breast-carcinoma/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=25313">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/25313/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=25313">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-25313.s19">
        <fig id="article-25313.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Mucinous Cancer Contributed by&#x000a0;S Bhimji, MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="mucinous__ca" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-25313.s20">
        <title>References</title>
        <ref id="article-25313.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kaoku</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Konishi</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Fujimoto</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Tohno</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Shiina</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Kondo</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Yamazaki</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kajihara</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Shinkura</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Yanagisawa</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Sonographic and pathologic image analysis of pure mucinous carcinoma of the breast.</article-title>
            <source>Ultrasound Med Biol</source>
            <year>2013</year>
            <month>Jul</month>
            <volume>39</volume>
            <issue>7</issue>
            <fpage>1158</fpage>
            <page-range>1158-67</page-range>
            <pub-id pub-id-type="pmid">23683410</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25313.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Di Saverio</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Gutierrez</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Avisar</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>A retrospective review with long term follow up of 11,400 cases of pure mucinous breast carcinoma.</article-title>
            <source>Breast Cancer Res Treat</source>
            <year>2008</year>
            <month>Oct</month>
            <volume>111</volume>
            <issue>3</issue>
            <fpage>541</fpage>
            <page-range>541-7</page-range>
            <pub-id pub-id-type="pmid">18026874</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25313.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zhang</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Jia</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Han</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Yang</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Xu</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>W</given-names>
              </name>
            </person-group>
            <article-title>Comparative analysis of imaging and pathology features of mucinous carcinoma of the breast.</article-title>
            <source>Clin Breast Cancer</source>
            <year>2015</year>
            <month>Apr</month>
            <volume>15</volume>
            <issue>2</issue>
            <fpage>e147</fpage>
            <page-range>e147-54</page-range>
            <pub-id pub-id-type="pmid">25523373</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25313.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Weigelt</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Horlings</surname>
                <given-names>HM</given-names>
              </name>
              <name>
                <surname>Kreike</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Hayes</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Hauptmann</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Wessels</surname>
                <given-names>LF</given-names>
              </name>
              <name>
                <surname>de Jong</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Van de Vijver</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Van't Veer</surname>
                <given-names>LJ</given-names>
              </name>
              <name>
                <surname>Peterse</surname>
                <given-names>JL</given-names>
              </name>
            </person-group>
            <article-title>Refinement of breast cancer classification by molecular characterization of histological special types.</article-title>
            <source>J Pathol</source>
            <year>2008</year>
            <month>Oct</month>
            <volume>216</volume>
            <issue>2</issue>
            <fpage>141</fpage>
            <page-range>141-50</page-range>
            <pub-id pub-id-type="pmid">18720457</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25313.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Toikkanen</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Eerola</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Ekfors</surname>
                <given-names>TO</given-names>
              </name>
            </person-group>
            <article-title>Pure and mixed mucinous breast carcinomas: DNA stemline and prognosis.</article-title>
            <source>J Clin Pathol</source>
            <year>1988</year>
            <month>Mar</month>
            <volume>41</volume>
            <issue>3</issue>
            <fpage>300</fpage>
            <page-range>300-3</page-range>
            <pub-id pub-id-type="pmid">2834422</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25313.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tan</surname>
                <given-names>PH</given-names>
              </name>
              <name>
                <surname>Tse</surname>
                <given-names>GM</given-names>
              </name>
              <name>
                <surname>Bay</surname>
                <given-names>BH</given-names>
              </name>
            </person-group>
            <article-title>Mucinous breast lesions: diagnostic challenges.</article-title>
            <source>J Clin Pathol</source>
            <year>2008</year>
            <month>Jan</month>
            <volume>61</volume>
            <issue>1</issue>
            <fpage>11</fpage>
            <page-range>11-9</page-range>
            <pub-id pub-id-type="pmid">17873114</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25313.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Righi</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Sapino</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Marchi&#x000f2;</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Papotti</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bussolati</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Neuroendocrine differentiation in breast cancer: established facts and unresolved problems.</article-title>
            <source>Semin Diagn Pathol</source>
            <year>2010</year>
            <month>Feb</month>
            <volume>27</volume>
            <issue>1</issue>
            <fpage>69</fpage>
            <page-range>69-76</page-range>
            <pub-id pub-id-type="pmid">20306832</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25313.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Komaki</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Sakamoto</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Sugano</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Morimoto</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Monden</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Mucinous carcinoma of the breast in Japan. A prognostic analysis based on morphologic features.</article-title>
            <source>Cancer</source>
            <year>1988</year>
            <month>Mar</month>
            <day>01</day>
            <volume>61</volume>
            <issue>5</issue>
            <fpage>989</fpage>
            <page-range>989-96</page-range>
            <pub-id pub-id-type="pmid">2827884</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25313.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Barkley</surname>
                <given-names>CR</given-names>
              </name>
              <name>
                <surname>Ligibel</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Wong</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Lipsitz</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>BL</given-names>
              </name>
              <name>
                <surname>Golshan</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Mucinous breast carcinoma: a large contemporary series.</article-title>
            <source>Am J Surg</source>
            <year>2008</year>
            <month>Oct</month>
            <volume>196</volume>
            <issue>4</issue>
            <fpage>549</fpage>
            <page-range>549-51</page-range>
            <pub-id pub-id-type="pmid">18809061</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25313.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lacroix-Triki</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Suarez</surname>
                <given-names>PH</given-names>
              </name>
              <name>
                <surname>MacKay</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Lambros</surname>
                <given-names>MB</given-names>
              </name>
              <name>
                <surname>Natrajan</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Savage</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Geyer</surname>
                <given-names>FC</given-names>
              </name>
              <name>
                <surname>Weigelt</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Ashworth</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Reis-Filho</surname>
                <given-names>JS</given-names>
              </name>
            </person-group>
            <article-title>Mucinous carcinoma of the breast is genomically distinct from invasive ductal carcinomas of no special type.</article-title>
            <source>J Pathol</source>
            <year>2010</year>
            <month>Nov</month>
            <volume>222</volume>
            <issue>3</issue>
            <fpage>282</fpage>
            <page-range>282-98</page-range>
            <pub-id pub-id-type="pmid">20815046</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25313.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Domfeh</surname>
                <given-names>AB</given-names>
              </name>
              <name>
                <surname>Carley</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Striebel</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Karabakhtsian</surname>
                <given-names>RG</given-names>
              </name>
              <name>
                <surname>Florea</surname>
                <given-names>AV</given-names>
              </name>
              <name>
                <surname>McManus</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Beriwal</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Bhargava</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>WT1 immunoreactivity in breast carcinoma: selective expression in pure and mixed mucinous subtypes.</article-title>
            <source>Mod Pathol</source>
            <year>2008</year>
            <month>Oct</month>
            <volume>21</volume>
            <issue>10</issue>
            <fpage>1217</fpage>
            <page-range>1217-23</page-range>
            <pub-id pub-id-type="pmid">18469795</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25313.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Adsay</surname>
                <given-names>NV</given-names>
              </name>
              <name>
                <surname>Merati</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Nassar</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Shia</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Sarkar</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Pierson</surname>
                <given-names>CR</given-names>
              </name>
              <name>
                <surname>Cheng</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Visscher</surname>
                <given-names>DW</given-names>
              </name>
              <name>
                <surname>Hruban</surname>
                <given-names>RH</given-names>
              </name>
              <name>
                <surname>Klimstra</surname>
                <given-names>DS</given-names>
              </name>
            </person-group>
            <article-title>Pathogenesis of colloid (pure mucinous) carcinoma of exocrine organs: Coupling of gel-forming mucin (MUC2) production with altered cell polarity and abnormal cell-stroma interaction may be the key factor in the morphogenesis and indolent behavior of colloid carcinoma in the breast and pancreas.</article-title>
            <source>Am J Surg Pathol</source>
            <year>2003</year>
            <month>May</month>
            <volume>27</volume>
            <issue>5</issue>
            <fpage>571</fpage>
            <page-range>571-8</page-range>
            <pub-id pub-id-type="pmid">12717243</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25313.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Komenaka</surname>
                <given-names>IK</given-names>
              </name>
              <name>
                <surname>El-Tamer</surname>
                <given-names>MB</given-names>
              </name>
              <name>
                <surname>Troxel</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Hamele-Bena</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Joseph</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Horowitz</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Ditkoff</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Schnabel</surname>
                <given-names>FR</given-names>
              </name>
            </person-group>
            <article-title>Pure mucinous carcinoma of the breast.</article-title>
            <source>Am J Surg</source>
            <year>2004</year>
            <month>Apr</month>
            <volume>187</volume>
            <issue>4</issue>
            <fpage>528</fpage>
            <page-range>528-32</page-range>
            <pub-id pub-id-type="pmid">15041505</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25313.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wilson</surname>
                <given-names>TE</given-names>
              </name>
              <name>
                <surname>Helvie</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Oberman</surname>
                <given-names>HA</given-names>
              </name>
              <name>
                <surname>Joynt</surname>
                <given-names>LK</given-names>
              </name>
            </person-group>
            <article-title>Pure and mixed mucinous carcinoma of the breast: pathologic basis for differences in mammographic appearance.</article-title>
            <source>AJR Am J Roentgenol</source>
            <year>1995</year>
            <month>Aug</month>
            <volume>165</volume>
            <issue>2</issue>
            <fpage>285</fpage>
            <page-range>285-9</page-range>
            <pub-id pub-id-type="pmid">7618541</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25313.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chang</surname>
                <given-names>YW</given-names>
              </name>
              <name>
                <surname>Kwon</surname>
                <given-names>KH</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>DW</given-names>
              </name>
            </person-group>
            <article-title>Synchronous bilateral mucinous carcinoma of the breast: case report.</article-title>
            <source>Clin Imaging</source>
            <year>2009</year>
            <season>Jan-Feb</season>
            <volume>33</volume>
            <issue>1</issue>
            <fpage>62</fpage>
            <page-range>62-6</page-range>
            <pub-id pub-id-type="pmid">19135933</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25313.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Memis</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ozdemir</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Parildar</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ustun</surname>
                <given-names>EE</given-names>
              </name>
              <name>
                <surname>Erhan</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Mucinous (colloid) breast cancer: mammographic and US features with histologic correlation.</article-title>
            <source>Eur J Radiol</source>
            <year>2000</year>
            <month>Jul</month>
            <volume>35</volume>
            <issue>1</issue>
            <fpage>39</fpage>
            <page-range>39-43</page-range>
            <pub-id pub-id-type="pmid">10930764</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25313.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Okafuji</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Yabuuchi</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Sakai</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Soeda</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Matsuo</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Inoue</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Hatakenaka</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Takahashi</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Kuroki</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Tokunaga</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Honda</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>MR imaging features of pure mucinous carcinoma of the breast.</article-title>
            <source>Eur J Radiol</source>
            <year>2006</year>
            <month>Dec</month>
            <volume>60</volume>
            <issue>3</issue>
            <fpage>405</fpage>
            <page-range>405-13</page-range>
            <pub-id pub-id-type="pmid">16963218</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25313.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yang</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Chun-Hong</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Lin-Ping</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Pure mucinous breast carcinoma: a favorable subtype.</article-title>
            <source>Breast Care (Basel)</source>
            <year>2013</year>
            <month>Mar</month>
            <volume>8</volume>
            <issue>1</issue>
            <fpage>56</fpage>
            <page-range>56-9</page-range>
            <pub-id pub-id-type="pmid">24715844</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25313.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Garcia Hernandez</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Canavati Marcos</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Garza Montemayor</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Lopez Sotomayor</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Pineda Ochoa</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Gomez Macias</surname>
                <given-names>GS</given-names>
              </name>
            </person-group>
            <article-title>Her-2 positive mucinous carcinoma breast cancer, case report.</article-title>
            <source>Int J Surg Case Rep</source>
            <year>2018</year>
            <volume>42</volume>
            <fpage>242</fpage>
            <page-range>242-246</page-range>
            <pub-id pub-id-type="pmid">29291541</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25313.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Park</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Koo</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Yang</surname>
                <given-names>WI</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>BW</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>KS</given-names>
              </name>
            </person-group>
            <article-title>Clinicopathological characteristics of mucinous carcinoma of the breast in Korea: comparison with invasive ductal carcinoma-not otherwise specified.</article-title>
            <source>J Korean Med Sci</source>
            <year>2010</year>
            <month>Mar</month>
            <volume>25</volume>
            <issue>3</issue>
            <fpage>361</fpage>
            <page-range>361-8</page-range>
            <pub-id pub-id-type="pmid">20191033</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25313.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Toikkanen</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kujari</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Pure and mixed mucinous carcinomas of the breast: a clinicopathologic analysis of 61 cases with long-term follow-up.</article-title>
            <source>Hum Pathol</source>
            <year>1989</year>
            <month>Aug</month>
            <volume>20</volume>
            <issue>8</issue>
            <fpage>758</fpage>
            <page-range>758-64</page-range>
            <pub-id pub-id-type="pmid">2545592</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
